
==== Front
NPJ Vaccines
NPJ Vaccines
NPJ Vaccines
2059-0105
Nature Publishing Group UK London

39300100
965
10.1038/s41541-024-00965-2
Author Correction
Author Correction: A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine
http://orcid.org/0009-0004-2141-2407
Kim Yoonjin 1
Bae Sungyeun 1
Yu Kyung-Sang 1
Lee SeungHwan 1
Lee Chankyu 2
Kim Jinil 2
Her Howard 2
Oh Jaeseong jaeseong5@jejunu.ac.kr

134
1 https://ror.org/04h9pn542 grid.31501.36 0000 0004 0470 5905 Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea
2 grid.497804.6 R&D Division, EuBiologics Co., Ltd, Seoul, Republic of Korea
3 https://ror.org/05hnb4n85 grid.411277.6 0000 0001 0725 5207 Department of Pharmacology, Jeju National University College of Medicine, Jeju, Republic of Korea
4 https://ror.org/05p64mb74 grid.411842.a 0000 0004 0630 075X Clinical Research Institute, Jeju National University Hospital, Jeju, Republic of Korea
19 9 2024
19 9 2024
2024
9 175© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Subject terms

Drug development
Meningitis
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcCorrection to: npj Vaccines 10.1038/s41541-024-00935-8, published online 07 August 2024

The original version of this article contained an error in the name of the analytical laboratory for immunogenicity assessment. The correct name is the UK Health Security Agency Vaccine Evaluation Unit (Manchester, United Kingdom), but it was incorrectly stated as the Department of Health and Social Care at the UK Health Security Agency (UKHSA, London, UK). This error has now been corrected in both the PDF and HTML versions of the article.
